サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1791545

牛の結核診断の世界市場

Bovine Tuberculosis Diagnosis

出版日
ページ情報
英文 183 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
牛の結核診断の世界市場
出版日: 2025年08月15日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

牛の結核診断の世界市場は2030年までに9億1,190万米ドルに達する見込み

2024年に7億6,360万米ドルと推定される牛の結核診断の世界市場は、分析期間2024-2030年にCAGR 3.0%で成長し、2030年には9億1,190万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである従来型検査は、CAGR 3.6％を記録し、分析期間終了時には4億7,440万米ドルに達すると予測されます。血清学的検査分野の成長率は、分析期間中CAGR 2.7%と推定されます。

米国市場は2億800万米ドルと推定、中国はCAGR 5.8％で成長予測

米国の牛の結核診断市場は、2024年に2億800万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億7,960万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは5.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.1%と2.3%と予測されています。欧州では、ドイツがCAGR 1.7%で成長すると予測されています。

世界の牛の結核診断市場- 主要動向と促進要因のまとめ

牛の結核診断を強化する技術的ブレークスルーとは？

牛結核（bTB）診断市場は、診断法やデジタルツールの進歩が、この重要な家畜疾病の検出と管理に革命をもたらしていることから、技術革新の急増を目の当たりにしています。ポリメラーゼ連鎖反応（PCR）アッセイや核酸増幅検査（NAAT）を含む最先端の分子診断法は、迅速かつ特異性の高いマイコバクテリウム・ボビスの検出を可能にし、正確な診断に必要な時間を大幅に短縮しています。インターフェロン-ガンマ放出アッセイ（IGRA）や酵素結合免疫吸着アッセイ（ELISA）などの免疫診断法の革新により、感度と特異性が向上し、牛の集団における早期発見が改善されつつあります。デジタル画像とコンピューター解析が診断手順に組み込まれ、検査結果の自動読み取りが可能になり、解釈における主観的なばらつきが減少しています。最近のポイントオブケア検査機器の開発により、家畜の現場でのスクリーニングが可能になり、これは遠隔地や資源が限られた環境では特に重要です。IoT対応のデータ収集システムとクラウドベースのプラットフォームの統合により、リアルタイムのサーベイランスと地域間の診断データの集約が容易になり、より効率的な疾病のモニタリングと発生への対応につながっています。低侵襲的手技を含むサンプル採取技術の進歩により、結核菌診断の信頼性と精度がさらに向上しています。こうした技術革新は、畜産セクターにおける効果的な疾病対策と管理に不可欠な診断のスピード、精度、拡張性を向上させ、市場を再構築しています。獣医学研究者、診断企業、政府機関の継続的な調査と協力的な取り組みにより、アッセイ性能と作業効率のさらなる向上が推進され、診断ツールが牛結核検出の進化する課題に対応できるようになっています。

最終用途と家畜管理の動向は結核診断にどのような影響を与えているか？

最終用途と家畜管理の動向は、牛の結核診断市場の形成に極めて重要な役割を果たしています。動物の健康と食の安全に対する世界の関心が高まる中、bTBを早期かつ正確に検出することは、持続可能な家畜管理とバイオセキュリティプロトコルの重要な要素となりつつあります。大規模な酪農・肉牛経営では、牛群の健康状態を積極的に監視し、感染リスクを低減し、結核の発生に伴う経済的損失を軽減するため、高度な診断技術に投資しています。強固な検査プロトコルは貿易基準を維持し、国際的な衛生規制を遵守するために不可欠であるため、診断能力の強化は政府や業界主導の撲滅プログラムも支援しています。農家や獣医師は、現場での迅速な検査を可能にするポイントオブケア診断ツールへの依存度を高めており、これによりタイムリーな意思決定や介入措置が容易になっています。デジタル・データ管理システムの獣医療現場への統合により、疾病の発生をリアルタイムで追跡できるようになり、これは的を絞ったサーベイランスとリスク評価に不可欠です。こうした動向は、安全で倫理的に生産された畜産物に対する消費者の要求の高まりによってさらに増幅され、利害関係者を厳格な疾病管理対策の導入へと駆り立てています。さらに、牛結核の負担が大きくなりがちな農村部や新興市場では、エンドユーザーのトレーニングや支援イニシアティブにより、高度な診断方法の採用が進んでいます。家畜管理がより技術主導のアプローチへと進化するにつれ、牛群全体の健康と持続可能な農業を支援する、革新的で正確かつ拡張性のある診断ソリューションに対する需要が高まっています。

どのような規制と市場力学がbTB診断セクターを形成しているのか？

牛の結核診断分野は、製品開発と普及の両方を推進する規制要件と市場力学の影響を強く受けています。各国の獣医局や世界獣疫事務局（OIE）などの国際機関を含む規制機関は、診断精度、バイオセーフティ、品質保証について厳しい基準を設けています。これらの規制を遵守するためには、アッセイの感度と特異性を高めるための研究開発に継続的に投資し、診断検査が最高の性能ベンチマークを満たすようにする必要があります。市場力学はまた、疾病の流行状況の変動、バイオセキュリティの要求、畜産業に対する経済的圧力によっても影響を受け、費用対効果の高い迅速な診断ソリューションの必要性を高めています。競合情勢は、検査プロトコルの標準化と承認プロセスの合理化を目的とした、診断会社、獣医学研究機関、政府機関の戦略的提携によって特徴付けられます。さらに、IoT対応モニタリングシステムやクラウドベースのデータ分析などのデジタル技術の進歩は、疾病サーベイランスやアウトブレイク管理に革命をもたらし、市場の対応力を高めています。世界の貿易規制と輸出基準は、家畜生産者に厳格な検査レジメンの採用をさらに迫り、それによって先進的なbTB診断ツールの需要を刺激しています。このような規制と市場力学が、この分野の技術革新と品質向上を継続的に推進するダイナミックな環境を作り出し、診断製品の信頼性、効率性、そして農業界への幅広いアクセスを確保しています。

bTB診断市場の成長はいくつかの要因によってもたらされる

牛の結核診断市場の成長は、大幅な技術進歩、最終用途の拡大、規制や市場ダイナミクスの進化など、いくつかの要因によって牽引されています。分子診断、イムノアッセイ、ポイントオブケア検査機器における技術革新は、結核菌検出のスピードと精度を向上させ、それによって経済的損失を削減し、牛群の健康管理を改善しています。動物の健康、食の安全、バイオセキュリティに対する世界の関心の高まりが、大規模な畜産事業や政府の撲滅プログラムによる需要を促進しています。さらに、デジタル監視システムとクラウドベースのデータ分析の統合により、リアルタイム監視と疾病発生への迅速な対応が可能になる一方、厳格な検査プロトコルに対する規制の義務化により、高水準の診断性能と安全性が保証されます。これらの技術的、最終用途的、規制的要因は、戦略的パートナーシップや継続的な研究開発投資と相まって、牛の結核診断市場を世界の持続的成長と農業生産性の向上に向けて推進しています。

セグメント

検査タイプ（従来型検査、血清学的検査、分子診断検査）

調査対象企業の例

  • Abbott Laboratories
  • AsureQuality Australia Pty Ltd
  • Biocheck UK Ltd
  • Bionote USA Inc.
  • BioNote, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-X Diagnostics
  • Chembio Diagnostics, Inc.
  • Creative Diagnostics
  • Eiken Chemical Co., Ltd.
  • Enfer Group
  • Fujirebio Europe NV
  • IDEXX Laboratories, Inc.
  • IDvet
  • Lionex GmbH
  • MegaCor Diagnostik GmbH
  • Molbio Diagnostics Pvt. Ltd.
  • PBD Biotech Ltd
  • Thermo Fisher Scientific Inc.
  • Zoetis Services LLC

AI統合

検証された専門家のコンテンツとAIツールにより、市場情報と競合情報を変革します。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP29691

Global Bovine Tuberculosis Diagnosis Market to Reach US$911.9 Million by 2030

The global market for Bovine Tuberculosis Diagnosis estimated at US$763.6 Million in the year 2024, is expected to reach US$911.9 Million by 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Traditional Tests, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$474.4 Million by the end of the analysis period. Growth in the Serological Tests segment is estimated at 2.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$208.0 Million While China is Forecast to Grow at 5.8% CAGR

The Bovine Tuberculosis Diagnosis market in the U.S. is estimated at US$208.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$179.6 Million by the year 2030 trailing a CAGR of 5.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Bovine Tuberculosis Diagnosis Market - Key Trends & Drivers Summarized

What Are the Technological Breakthroughs Enhancing Bovine Tuberculosis Diagnosis?

The bovine tuberculosis (bTB) diagnosis market is witnessing a surge in technological innovation, as advancements in diagnostic methods and digital tools are revolutionizing the detection and management of this critical livestock disease. State-of-the-art molecular diagnostics, including polymerase chain reaction (PCR) assays and nucleic acid amplification tests (NAATs), are providing rapid and highly specific detection of Mycobacterium bovis, significantly reducing the time needed for accurate diagnosis. Innovations in immunodiagnostic methods, such as interferon-gamma release assays (IGRAs) and enzyme-linked immunosorbent assays (ELISAs), are enhancing sensitivity and specificity, thereby improving early detection in cattle populations. Digital imaging and computerized analysis are being integrated into diagnostic procedures, enabling automated reading of test results and reducing subjective variability in interpretations. Recent developments in point-of-care testing devices allow for on-site screening of livestock, which is particularly critical in remote or resource-limited settings. The integration of IoT-enabled data collection systems and cloud-based platforms is facilitating real-time surveillance and the aggregation of diagnostic data across regions, leading to more efficient disease monitoring and outbreak response. Advances in sample collection techniques, including minimally invasive procedures, are further improving the reliability and accuracy of bTB diagnosis. These technological innovations are reshaping the market by enhancing diagnostic speed, accuracy, and scalability, which are essential for effective disease control and management in the livestock sector. Continuous research and collaborative efforts among veterinary researchers, diagnostic companies, and government agencies are driving further improvements in assay performance and operational efficiency, ensuring that the diagnostic tools keep pace with the evolving challenges of bovine tuberculosis detection.

How Are End-Use Applications and Livestock Management Trends Influencing bTB Diagnosis?

The end-use applications and evolving trends in livestock management are playing a pivotal role in shaping the bovine tuberculosis diagnosis market. With the increasing global focus on animal health and food safety, early and accurate detection of bTB is becoming a critical component of sustainable livestock management and biosecurity protocols. Large-scale dairy and beef operations are investing in advanced diagnostic technologies to monitor herd health proactively, reduce transmission risks, and mitigate economic losses associated with bTB outbreaks. Enhanced diagnostic capabilities are also supporting government and industry-led eradication programs, as robust testing protocols are essential for maintaining trade standards and ensuring compliance with international health regulations. Farmers and veterinarians are increasingly relying on point-of-care diagnostic tools that enable rapid on-site testing, thereby facilitating timely decision-making and intervention measures. The integration of digital data management systems into veterinary practices is allowing for real-time tracking of disease incidence, which is crucial for targeted surveillance and risk assessment. These trends are further amplified by the growing consumer demand for safe and ethically produced animal products, driving stakeholders to adopt rigorous disease control measures. Additionally, end-user training and support initiatives are enhancing the adoption of advanced diagnostic methods in rural and emerging markets, where the burden of bovine tuberculosis is often higher. As livestock management practices evolve towards more technologically driven approaches, the market for bTB diagnosis is witnessing increased demand for innovative, accurate, and scalable diagnostic solutions that support overall herd health and sustainable agricultural practices.

What Regulatory and Market Dynamics Are Shaping the bTB Diagnosis Sector?

The bovine tuberculosis diagnosis sector is strongly influenced by regulatory requirements and market dynamics that drive both product development and adoption. Regulatory agencies, including national veterinary services and international bodies such as the World Organisation for Animal Health (OIE), enforce stringent standards for diagnostic accuracy, biosafety, and quality assurance. Compliance with these regulations necessitates continuous investment in research and development to enhance assay sensitivity and specificity, ensuring that diagnostic tests meet the highest performance benchmarks. Market dynamics are also affected by fluctuating disease prevalence, biosecurity demands, and economic pressures on livestock industries, which drive the need for cost-effective, rapid diagnostic solutions. The competitive landscape is characterized by strategic collaborations between diagnostic companies, veterinary research institutions, and government agencies to standardize testing protocols and streamline approval processes. Moreover, advancements in digital technologies, such as IoT-enabled monitoring systems and cloud-based data analytics, are revolutionizing disease surveillance and outbreak management, thus enhancing market responsiveness. Global trade regulations and export standards further compel livestock producers to adopt rigorous testing regimens, thereby stimulating demand for advanced bTB diagnostic tools. These regulatory and market forces create a dynamic environment that continually drives innovation and quality improvement in the bovine tuberculosis diagnosis sector, ensuring that diagnostic products remain reliable, efficient, and widely accessible to the agricultural community.

The Growth in the bTB Diagnosis Market Is Driven by Several Factors…

The growth in the bovine tuberculosis diagnosis market is driven by several factors, including significant technological advancements, expanding end-use applications, and evolving regulatory and market dynamics. Innovations in molecular diagnostics, immunoassays, and point-of-care testing devices are enhancing the speed and accuracy of bTB detection, thereby reducing economic losses and improving herd health management. The increasing global focus on animal health, food safety, and biosecurity is driving demand from large-scale livestock operations and government eradication programs. Furthermore, the integration of digital surveillance systems and cloud-based data analytics is enabling real-time monitoring and rapid response to disease outbreaks, while regulatory mandates for rigorous testing protocols ensure high standards of diagnostic performance and safety. These technological, end-use, and regulatory factors, combined with strategic partnerships and continuous R&D investments, are propelling the bovine tuberculosis diagnosis market toward sustained global growth and enhanced agricultural productivity.

SCOPE OF STUDY:

The report analyzes the Bovine Tuberculosis Diagnosis market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Traditional Tests, Serological Tests, Molecular Diagnostic Tests)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • AsureQuality Australia Pty Ltd
  • Biocheck UK Ltd
  • Bionote USA Inc.
  • BioNote, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-X Diagnostics
  • Chembio Diagnostics, Inc.
  • Creative Diagnostics
  • Eiken Chemical Co., Ltd.
  • Enfer Group
  • Fujirebio Europe NV
  • IDEXX Laboratories, Inc.
  • IDvet
  • Lionex GmbH
  • MegaCor Diagnostik GmbH
  • Molbio Diagnostics Pvt. Ltd.
  • PBD Biotech Ltd
  • Thermo Fisher Scientific Inc.
  • Zoetis Services LLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Bovine Tuberculosis Diagnosis - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Bovine Tuberculosis Drives Demand for Advanced Diagnostic Solutions
    • Stringent Government Regulations and Disease Control Programs Strengthen Market for Bovine TB Testing
    • Advancements in Molecular Diagnostics Enhance Early and Accurate Detection of Bovine TB
    • Increasing Use of ELISA and PCR-Based Assays Expands Diagnostic Capabilities in Veterinary Medicine
    • Surge in Demand for Portable and Rapid On-Site Testing Kits Improves Disease Surveillance in Livestock
    • Growing Adoption of AI and Machine Learning in Disease Detection Strengthens Market for Smart Diagnostic Tools
    • Expansion of Livestock Farming and Dairy Industry Spurs Market for Regular TB Screening Programs
    • Increasing Investment in Veterinary Healthcare and Research Supports Development of Next-Gen TB Tests
    • Rising Concerns Over Zoonotic Transmission of Bovine TB Fuels Global Efforts for Disease Eradication
    • Regulatory Approvals and Standardization of Diagnostic Tests Improve Market Accessibility and Compliance
    • Growth in Public-Private Partnerships Enhances Availability and Affordability of TB Diagnosis in Developing Regions
    • Emerging Role of Genetic and Biomarker-Based Testing in Precision TB Diagnosis Gains Traction
    • Integration of Blockchain and Digital Health Records Strengthens Disease Tracking and Reporting Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bovine Tuberculosis Diagnosis Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bovine Tuberculosis Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Bovine Tuberculosis Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Traditional Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Traditional Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Traditional Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Serological Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Serological Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Serological Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Molecular Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Molecular Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Molecular Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bovine Tuberculosis Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • JAPAN
    • Bovine Tuberculosis Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • CHINA
    • Bovine Tuberculosis Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • EUROPE
    • Bovine Tuberculosis Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Bovine Tuberculosis Diagnosis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Bovine Tuberculosis Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • FRANCE
    • Bovine Tuberculosis Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • GERMANY
    • Bovine Tuberculosis Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bovine Tuberculosis Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bovine Tuberculosis Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Bovine Tuberculosis Diagnosis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Bovine Tuberculosis Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Bovine Tuberculosis Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • INDIA
    • Bovine Tuberculosis Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Bovine Tuberculosis Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Bovine Tuberculosis Diagnosis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Bovine Tuberculosis Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Bovine Tuberculosis Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Bovine Tuberculosis Diagnosis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Bovine Tuberculosis Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030
  • AFRICA
    • Bovine Tuberculosis Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Bovine Tuberculosis Diagnosis by Test Type - Traditional Tests, Serological Tests and Molecular Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Bovine Tuberculosis Diagnosis by Test Type - Percentage Breakdown of Value Sales for Traditional Tests, Serological Tests and Molecular Diagnostic Tests for the Years 2015, 2025 & 2030

IV. COMPETITION